← Back to headlines
Analyst Optimistic on Terns Pharmaceuticals' Upcoming Leukemia Drug
An analyst expresses optimism regarding Terns Pharmaceuticals (TERN) and its upcoming leukemia drug, projecting a potential market value of $4.8 billion for the treatment.
27 Feb, 21:04 — 27 Feb, 21:04
Sources
Showing 1 of 1 sources
